Bayesian dose escalation in oncology with sharing of information between patient populationsKristine Broglio, Scott Berry, Larissa Sandalic et al.|Contemporary Clinical Trials|2015Cited by 5
Vispa-Cel, an Allogeneic Anti-CD19 CAR-T cell Therapy with a PD-1 Knockout, In Patients with relapsed/refractory B cell Non-Hodgkin Lymphoma (r/r B-NHL): Updated Results from the Antler Phase 1 Clinical TrialMehdi Hamadani, Susan O'Brien, James Essell et al.|Transplantation and Cellular Therapy|2026Cited by 0